Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Adenocarcinoma, Follicular × Thyrotropin Alfa × Clear all

Phase

Phase 2 2 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Endocrine 1

Conditions

Thyroid Neoplasms 2 Thyroid Cancer, Papillary 1 Low Risk Differentiated Thyroid Cancer 1 Differentiated Thyroid Cancer 1 Adenocarcinoma, Follicular 1

Interventions

cabozantinib 1 Thyrotropin Alfa 1 Injections 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00295763 2015-03-18

A New Study to Follow-up Thyroid Cancer Patients Who Participated in a Previous Study, Which Compared the Success of Destruction of the Thyroid Remnant Using Standard Treatment or Thyrogen.

Sanofi

Phase 3 Completed

EndocrineHead & Neck

Thyroid Cancer, Papillary, Adenocarcinoma, Follicular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡